Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
6
×
seattle top stories
boston blog main
boston top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
cancer
fda
roche
checkpoint inhibitors
drugs
larotrectinib
loxo oncology
lung cancer
merck
sage therapeutics
acadia pharmaceuticals
adverum biotechnologies
What
cancer
6
×
drug
6
×
medicine
fda
roundup
tiny
adding
advanced
ahead
alzheimer's
ambien
american
annual
approved
arrival
asco
attendees
attention
award
bad
bets
bio
biotech
boost
brain
camp’s
case
cash
chicago
city
clinical
combinations
community’s
data
days
death
decades
deeper
dems
disease
Language
unset
Current search:
drug
×
" seattle blog main "
×
photo
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More